• Immunome granted equity awards to 17 new employees on November 2, 2026, under its 2024 Inducement Plan.
• The awards comprise non-statutory stock options to purchase 206,700 common shares and 103,350 restricted stock units (RSUs).
• Options vest over four years: 25% on the first anniversary of the vesting commencement date, with the balance monthly over 36 months.
• RSUs vest over four years, with 25% vesting on each anniversary of the vesting commencement date.
• Vesting of both awards requires continued service through the applicable vesting dates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261106493528) on November 06, 2026, and is solely responsible for the information contained therein.